secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2026-09-01T13:23:17+00:00
Accession:  0001193125-26-377696
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin completes acquisition of Alesta Therapeutics B.V.
----------------------------------------------------------

- Completed share purchase of Alesta Therapeutics on Aug 31, 2026; Alesta now wholly owned subsidiary.
- Acquisition follows Share Purchase Agreement first filed Aug 18, 2026; no new deal terms disclosed.
- BioMarin (BMRN) expands portfolio via Alesta; purchase price not stated in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/0001193125-26-377696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/d110660d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-377696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer